Puma Biotechnology, Inc. (PBYI) vs Shattuck Labs, Inc. (STTK)
- Puma Biotechnology, Inc. PBYI 9.83 −6.56%
- Shattuck Labs, Inc. STTK 5.42 −1.99%
Puma Biotechnology, Inc. and Shattuck Labs, Inc. are both Biotechnology companies. Puma Biotechnology, Inc. and Shattuck Labs, Inc. are of similar size ($555.0M and $543.0M). Shattuck Labs, Inc. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.2×. Shattuck Labs, Inc. grew revenue faster over the last twelve months: 106.5% against −2.86%. Puma Biotechnology, Inc. has the higher net margin (11.6% vs 0.00%) and the higher return on invested capital (42.6% vs −1,230.7%). Across the 17 metrics below, Puma Biotechnology, Inc. leads on 12 and Shattuck Labs, Inc. on 5.
Valuation
Profitability
| Metric | PBYI | STTK | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.83% | 100.00% | 65.16% |
| Operating margin | 13.16% | 0.00% | 0.00% |
| Net margin | 11.55% | 0.00% | 0.00% |
| Free cash flow margin | 17.79% | 0.00% | 0.00% |
| Return on equity | 21.97% | (39.21%) | (56.36%) |
| Return on assets | 13.78% | (36.88%) | (48.04%) |
| Return on invested capital | 42.61% | (1,230.74%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack